Microbial cell factories for Pharmaceuticals,
Biopolymers and High Value Products
Optimisation of microorganisms to be used industrially is a prerequisite for process economics and quality of the produced product.
The main objective for this SUB-project is to develop new and improved microbial strains for targeted direct application (e.g., live vaccines) and host systems, tailored for the robust and efficient production of targeted compounds in conventional and/or gas fermentation.
To achieve this goal, we will use existing state-of-the-art methods like predictive systems-scale models, synthetic biology principles-based strain engineering and/or classical strain improvement and laboratory evolution approaches as well as develop new technologies to approach novel challenges.